Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events

Vanishing bile duct syndrome (VBDS) is a rare hepatic disorder which leads to liver failure as a result of progressive destruction of the intrahepatic bile ducts. There are no treatment modalities for VBDS itself and severe hepatic dysfunction restricts the treatment of underlying diseases. We safel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishitsuka, Kantaro, Yokoyama, Yasuhisa, Baba, Naoko, Matsuoka, Ryota, Sakamoto, Noriaki, Sakamoto, Tatsuhiro, Kusakabe, Manabu, Kato, Takayasu, Kurita, Naoki, Nishikii, Hidekazu, Sakata-Yanagimoto, Mamiko, Obara, Naoshi, Hasegawa, Yuichi, Chiba, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635035/
https://www.ncbi.nlm.nih.gov/pubmed/35831099
http://dx.doi.org/10.3960/jslrt.21035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635035/
https://www.ncbi.nlm.nih.gov/pubmed/35831099
http://dx.doi.org/10.3960/jslrt.21035

Ejemplares similares